When Perception Limited Growth, We Redefined the Market.

CASE STUDY | ADVERTISING

When Perception Limited Growth, We Redefined the Market.

THE CHALLENGE

Overcoming Constrained Market Perception to Unlock Broader Relevance

A leading global pharmaceutical company was facing increasing competitive pressure within a highly competitive cardio-metabolic therapeutic area. While the product was widely recognized in the market, its perceived value had become narrowly defined around one important benefit.

This constrained perception limited relevance across broader patient populations who could benefit from the therapy’s full clinical profile, including its impact on glycemic control, weight management, and cardiovascular risk. At the same time, a competitor was increasing pressure on the brand, threatening long-term growth potential.

To sustain leadership, the brand needed to expand beyond its established positioning and strengthen relevance across a broader clinical and patient landscape.

THE BREAKTHROUGH

Redefining the Therapy’s Role Across Cardio-Metabolic Risk Factors

BGBx identified that the barrier to increased adoption was not awareness, but entrenched clinical perception. The therapy was narrowly associated with a single outcome, limiting recognition of its broader clinical value. The breakthrough repositioned the brand as a multi-dimensional therapy addressing interconnected cardio-metabolic risk factors

Using our proprietary Breakthrough Process, powered by 3D Science, we validated strategy at every stage of development. Hypotheses were tested against market realities, strategic concepts were validated with target audiences, and creative execution was proven before scaling investment. This reshaped perception and expanded consideration across HCP and patient audiences. A unified brand platform reinforced value across multiple clinical outcomes.

The approach integrated:

Patient storytelling with real-world profiles to increase relevance
HCP engagement materials reinforcing expanded clinical use and patient applicability
Payer and access integration to align across the full decision ecosystem
Omnichannel activation across TV, digital, social, and HCP channels
Coordinated communications to extend positioning beyond a single outcom

This coordinated effort expanded clinical relevance and strengthened how the therapy was understood across stakeholders.

Perspective

“This campaign was successful because we transformed how the therapy was understood. We shifted both patient and provider perspectives, driving measurable growth.”

— Commercial Strategy Lead

THE RESULTS

Expanded Relevance Driving Adoption and Engagement

Strengthened brand impact through high-performing, differentiated messaging
Expanded visibility across both patient and healthcare provider audiences
Increased physician-led discussions focused on cardiovascular risk
Supported continued growth and strong market share within a highly competitive therapeutic category

The result was a measurable shift in how the therapy was perceived, expanding its clinical relevance beyond a single outcome.

96%
Brand Linkage

Record-breaking
TV performance

230M Audience Impressions

Expanded patient and
provider reach

+20%
Physician Discussions

Increased focus on
cardiovascular risk